Cargando…

Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer

Detalles Bibliográficos
Autores principales:	Vlayen, Joan, Belderbos, José, Widder, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471792/ https://www.ncbi.nlm.nih.gov/pubmed/26054037 http://dx.doi.org/10.1111/cas.12659

Ejemplares similares

Response to “A meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer”
por: Ma, Jie-tao, et al.
Publicado: (2015)

Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer
por: Ma, Jie-Tao, et al.
Publicado: (2014)

Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
por: Lewis, T.S., et al.
Publicado: (2020)

Postoperative radiotherapy for prostate cancer: Morbidity of local-only or local-plus-pelvic radiotherapy
por: Waldstein, Cora, et al.
Publicado: (2017)

Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
por: Ampil, Federico L., et al.
Publicado: (2011)

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer
por: Hoeltgen, Line, et al.
Publicado: (2023)

Comparative Evaluation of Three Palliative Radiotherapy Schedules in Locally Advanced Head and Neck Cancer
por: Soni, Abhishek, et al.
Publicado: (2017)

Hypofractionated Radiotherapy for Palliation in Locally Advanced Head and Neck Cancer
por: Spartacus, RK, et al.
Publicado: (2017)

Use of radiotherapy in patients with palliative double bypass for locally advanced pancreatic adenocarcinoma
por: Glinka, Juan, et al.
Publicado: (2018)

Clinical Outcome of Palliative Radiotherapy for Locally Advanced Symptomatic Gastric Cancer in the Modern Era
por: Tey, Jeremy, et al.
Publicado: (2014)

Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
por: Tey, Jeremy, et al.
Publicado: (2019)

Different fractionation regimes in palliative thoracic radiotherapy: Some facets
por: Sharma, Mukesh, et al.
Publicado: (2015)

Feasibility of Fewer Fraction Palliative Radiotherapy in Resource-Limited Setting
por: Dulal, Soniya, et al.
Publicado: (2020)

Ultra-Low-Dose Radiotherapy for Palliation of Mycosis Fungoides
por: Aral, İpek Pınar, et al.
Publicado: (2020)

Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience
por: Das, Saikat, et al.
Publicado: (2013)

Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes
por: Paliwal, Rajan, et al.
Publicado: (2012)

A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC
por: Michael, M, et al.
Publicado: (2005)

Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia
por: YAMASHITA, MAMI, et al.
Publicado: (2015)

Palliative radiotherapy for gross hematuria in patients with advanced cancer
por: Ogita, Mami, et al.
Publicado: (2021)

Palliative radiotherapy
por: Spencer, Katie, et al.
Publicado: (2018)

Palliative radiotherapy for gastric cancer: Is there a dose relationship between bleeding response and radiotherapy?
por: Viani, Gustavo Arruda, et al.
Publicado: (2020)

Palliative low dose fortnightly methotrexate in oral cancer
por: Tin, Sim Sai, et al.
Publicado: (2015)

Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: “MTD” or “ALARA”?
por: Ohri, Nitin
Publicado: (2017)

Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2020)

Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?
por: Nieder, Carsten, et al.
Publicado: (2017)

Quality of Life in Patients Treated with Palliative Radiotherapy for Advanced Lung Cancer and Lung Metastases
por: Koo, Kaitlin, et al.
Publicado: (2011)

Higher dose statins after stroke
Publicado: (2021)

Human papillomavirus vaccine – lower risk, higher benefit
por: Mondal, Shaikat, et al.
Publicado: (2020)

Challenges in the target volume definition of lung cancer radiotherapy
por: Mercieca, Susan, et al.
Publicado: (2021)

The higher temperature and ultraviolet, the lower COVID-19 prevalence–meta-regression of data from large US cities
por: Takagi, Hisato, et al.
Publicado: (2020)

Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2021)

Levels of Anxiety and Depression Before Palliative Reirradiation Are Comparable to Those Before First Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2018)

Fexofenadine in higher doses in chronic spontaneous urticaria
por: Godse, Kiran V., et al.
Publicado: (2010)

Remdesivir for COVID-19: Why Not Dose Higher?
por: Yan, Victoria C., et al.
Publicado: (2021)

Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
por: Anderson, Justin D., et al.
Publicado: (2021)

Local radiotherapy for palliation in multiple myeloma patients with symptomatic bone lesions
por: Lee, Jeong Won, et al.
Publicado: (2016)

Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?—a narrative review by the international geriatric radiotherapy group
por: Vinh-Hung, Vincent, et al.
Publicado: (2022)

Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer
por: Belderbos, J, et al.
Publicado: (2007)

Dose-Escalated Intensity-Modulated Radiotherapy for the Management of Locally Advanced Cervical Cancer
por: Shewalkar, Balaji, et al.
Publicado: (2022)

Response to “Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?”
por: Kepka, Lucyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gh6jvh05lgflc4q4u3no29v11t